Imiquimod: An Effective Alternative for the Treatment of Invasive Cutaneous Squamous Cell Carcinoma
- 21 March 2006
- journal article
- case report
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 31 (3) , 371-374
- https://doi.org/10.1111/j.1524-4725.2005.31093
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Death Receptor-Independent Apoptosis in Malignant Melanoma Induced by the Small-Molecule Immune Response Modifier ImiquimodJournal of Investigative Dermatology, 2004
- Successful Treatment of Invasive Squamous Cell Carcinoma Using Topical ImiquimodArchives of Dermatology, 2004
- Induction of apoptosis by Toll-like receptor-7 agonist in tissue culturesBritish Journal of Dermatology, 2003
- Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicleBritish Journal of Dermatology, 2003
- Mechanisms Underlying Imiquimod-Induced Regression of Basal Cell Carcinoma In VivoArchives of Dermatology, 2003
- DNA repair and nonmelanoma skin cancer in Puerto Rican populationsJournal of the American Academy of Dermatology, 2003
- Tumor-Selective Induction of Apoptosis and the Small-Molecule Immune Response Modifier ImiquimodJNCI Journal of the National Cancer Institute, 2003
- From actinic keratosis to squamous cell carcinomaBritish Journal of Dermatology, 2002
- Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathwayNature Immunology, 2002
- Immunomodulatory and pharmacologic properties of imiquimodJournal of the American Academy of Dermatology, 2000